#DYK: Though kidneys are the most-transplanted organ, the waitlist for a kidney grows longer each year. Learn more about kidney health from National Kidney Foundation: bit.ly/3HFdL3v

A new paper authored by our Chief Medical Officer Nancy Krieger and leading #scleroderma experts Dr. Dinesh Khanna (Dr. Dinesh Khanna) & Dr. Keith Sullivan reviews new cell therapies in development for treating #autoimmune diseases. bit.ly/3iTOloA

Today we’re attending #ASTSWinter hosted by ASTS. We look forward to connecting with #transplant professionals who share our dedication to improving patients’ lives. Visit our booth to learn more about Talaris’ solid #organtransplant clinical trial.

Talaris’ #FREEDOM1 study is evaluating the potential of our investigational #stemcell therapy, FCR001, to free #livingdonor #kidneytransplant recipients from chronic immunosuppression. See if you qualify: bit.ly/2RuIkRO

Empowered. Compassionate. Energized. Revolutionary. These are the four core values #TeamTalaris embodies every day as we continue harnessing the power of immune tolerance to improve people’s lives. Learn more about Talaris’ culture at: bit.ly/3PjWT49

Talaris Patient Advisory Board member Gisela Delgado recently shared her experience being on #immunosuppressive medicines after her #kidneytransplant as a panelist at the TTS 2022 Congress. See an excerpt of her talk: youtu.be/KSiF3bd91PM

Our #FREEDOM2 clinical trial is evaluating whether FCR001, our investigational #celltherapy, can induce #immune tolerance in recent #livingdonor #kidneytransplant recipients without depending on #antirejection drugs. Visit our website for more info: bit.ly/33OMn1M

#ICYMI – Talaris Chief Human Resource Officer Andrew Farnsworth recently shared his insights on how organizations can be successful in establishing core values. Read his reflections here: bit.ly/3BsGa9i

Talaris is at NKF Serving Ohio’s 2023 Kidney & Transplant Symposium and will spend the day with renal professionals discussing the treatment of #kidneydisease, #transplantation, and #organdonation. Learn how to support those affected by kidney disease: bit.ly/3ZQmbMl

The #FREEDOM1 trial is enrolling individuals seeking a #livingdonor #kidneytransplant. Curious if you or a loved one might qualify? Find out by taking a short quiz: bit.ly/3HKm0uM #kidneys #organdonation #antirejection #transplantlife

Check out PKD Foundation’s helpful tips for #kidneypatients on how to prepare for a #kidneytransplant. To learn more on how to join their united fight to #endPKD visit: bit.ly/3R3Rqj6

Check out our latest video featuring patient advocate and transplant recipient Kevin Fowler (Kevin J. Fowler Principal The Voice of the Patient), about the importance of embracing a healthy lifestyle after a #kidneytransplant: bit.ly/40D66Ko

Talaris is pleased to share that our FREEDOM-1 trial is now enrolling at #UTSouthwestern Medical Center (@UTSWNews). For more information on FREEDOM-1, our phase 3 trial for living donor #kidneytransplant patients, visit: bit.ly/3HKm0uM #UTSW #DallasCounty

Today we’re at the 2023 Hypertension & Kidney Transplantation Update for the Clinician hosted by @MayoClinicEd. This three-day symposium will allow healthcare professionals to discuss clinical nephrology advancements. For more: mayocl.in/3R7GMYA

#February11, or International Day of Women and Girls in Science, is a time to honor all the women on #TeamTalaris. Learn more about what motivates our very own Rubina Pal and Hayley Squires who have chosen a career in life sciences. #WomenInScience #STEM #IDWGIS

#TeamTalaris is on a mission to harness the power of immune tolerance to improve people’s lives. Our most important asset in that work is our people, people like Tyrell. Learn more about our team: bit.ly/3HoYjIt #Louisville #Houston #Boston

Today we celebrate #NationalDonorDay and support Donate Life America’s commitment to spreading awareness and education about #organdonation. To change the future of someone in great need, consider giving the gift of life. Register to be an organ donor at registerme.org

We’re in Orlando for #Tandem23 hosted by ASTCT and CIBMTR and looking forward to sharing poster presentations on the design of our 3 #celltherapy clinical trials. Stop by our booth to learn more: bit.ly/3kJd0x5

Today on #RareDiseaseDay, the National @scleroderma Foundation will be among the many groups worldwide calling attention to rare diseases. Follow along their page as they highlight the faces of #scleroderma every hour today. Rare Disease Day

#AutoimmuneDiseaseAwarenessMonth is an opportunity to honor the millions of people worldwide living with autoimmune conditions, including #scleroderma. We’re proud to be part of the research community working to deliver better treatments for autoimmune diseases.